Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT02331212

Withdrawn

Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer

Stage IV Breast Cancer | Breast Carcinoma Metastatic to the Bone
NCT00522457

Terminated

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy

Advanced Breast Cancer | Metastatic Breast Cancer
NCT06008158

Active, not recruiting

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma | Estrogen Receptor-Positive Breast Carcinoma
NCT05539365

Withdrawn

Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma
NCT02415387

Completed

Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer (IMPACT)

Depression | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Cognitive Side Effects of Cancer Therapy
NCT00118157

Completed

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Male Breast Carcinoma
NCT06984250

Recruiting

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer (HFCBB)

Early Breast Cancer | Ductal Breast Carcinoma In Situ
NCT06671912

Suspended

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial (LoTam)

Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma | Anatomic Stage 1 Breast Cancer AJCC v8 | Estrogen Receptor-Positive Breast Carcinoma
NCT03324802

Completed

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7
NCT01276496

Completed

Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid Neoplasm
NCT05912231

Active, not recruiting

Ultrahypofractionation and Normal Tissue Toxicity

Myocardial Fibrosis | Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III
NCT01243541

Terminated

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Pain | Peripheral Neuropathy | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
NCT07610720

Recruiting

Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer

HER2-Positive Metastatic Breast Cancer | Advanced/Metastatic Breast Cancer
NCT07570524

Not yet recruiting

Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer (PRIME-TNBC)

Triple-negative Breast Cancer (TNBC)
NCT07507890

Recruiting

Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer (Mini-B)

Breast Cancer | Breast Cancer - Ductal Carcinoma in Situ (DCIS)
NCT07342283

Recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Triple Negative Breast Cancer (TNBC)
NCT07208149

Recruiting

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

Triple-Negative Breast Cancer (TNBC)
NCT07178171

Recruiting

A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

TNBC, Triple Negative Breast Cancer
NCT07063667

Not yet recruiting

Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer

Breast Cancer, Metastatic | Artifical Intelligence
NCT07047365

Recruiting

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

HER2-positive Advanced Breast Cancer
NCT06966050

Recruiting

Multi-center MRD Registry for Inflammatory Breast Cancer

Breast Cancer
NCT06773143

Recruiting

Effect of Subanesthetic Dose of Esketamine on Sleep Quality (EOSDOEOSQ)

Insomnia | Breast Cancer Surgery | Esketamine
NCT06682195

Recruiting

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

TNBC, Triple Negative Breast Cancer
NCT06556862

Not yet recruiting

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

HR+/HER2- Advanced Breast Cancer
NCT06551116

Recruiting

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer
NCT06099769

Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT06050109

Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Endocrine Therapy | Breast Cancer Female
NCT05883852

Recruiting

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

HER2 Positive Early Breast Cancer
NCT05856383

Recruiting

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC (HER2-VIP)

HER2-positive Advanced Breast Cancer
NCT05398861

Recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
NCT04967976

Recruiting

Breast Mesh Used in Two-staged Breast Reconstruction

Breast Cancer | Breast Reconstruction | Radiation | Synthetic Mesh
NCT04767659

Recruiting

Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging

Chemotherapy Effect | Breast Cancer Female
NCT04644406

Not yet recruiting

PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study (PETRA)

HER-2 Positive Breast Cancer
NCT04626986

Recruiting

Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor

Breast Tumor | Microwave Ablation | Breast Conserving Surgery
NCT04458532

Recruiting

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Early Stage Breast Cancer
NCT03390894

Recruiting

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Invasive Breast Cancer Early Stages
NCT03616587

Active, not recruiting

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. (SERENA-1)

ER+ HER2- Advanced Breast Cancer
NCT07484776

Active, not recruiting

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Triple-Negative Breast Cancer (TNBC)
NCT04494425

Active, not recruiting

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer (DB-06)

Advanced or Metastatic Breast Cancer
NCT05113251

Active, not recruiting

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

Breast Cancer | Breast Neoplasms | HER2-positive Early Breast Cancer
NCT01984138

Active, not recruiting

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy (REVIVE)

Breast Cancer | Estrogen Receptor Positive Breast Cancer
NCT06961331

Completed

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Metastatic HER2+ Advanced Breast Cancer
NCT06613516

Withdrawn

Effect of Capivasertib on ctDNA in ER Positive Breast Cancer (CaptAin)

Breast Cancer | Oestrogen Receptor Positive Breast Cancer
NCT04473040

Available

Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer

HR+, HER2-, Advanced Breast Cancer
NCT01992952

Active, not recruiting

Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer (FAKTION)

Estrogen Receptor Positive Breast Cancer
NCT06597175

Completed

Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy (ORIGO)

Breast Cancer | Breast Tumor | Mammary Carcinoma, Human
NCT07086196

Completed

A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

Metastatic HR+/HER2- Breast Cancer
NCT02238808

Active, not recruiting

A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (PRESTO)

Estrogen Receptor Positive Breast Cancer
NCT06945224

Active, not recruiting

A ReaL World Study of DS-8201 (EXPLORE)

Breast Cancer Metastatic | Treatment Efficacy
NCT02216786

Completed

A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer (MANTA)

Estrogen Receptor Positive Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations